Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán

Institution (Facility)

Also Known As

Instituto Nacional de Ciencias Médicas y Nutrición, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, National Institute of Medical Sciences and Nutrition Salvador Zubirán · Acronym: INCMNSZ

17.4K

Publications

965K

Citations

3.2K

Authors

1.3K

Concepts

About

Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán is a facility institution in Mexico City, Mexico known for medicine, public health, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Health Sciences	62	1K	55.7K
2	Engineering	28	141	5.9K
3	Education	15	36	1.4K
4	Arts	3	8	362
5	Business	2	7	367

Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán

17.4K

Publications

965K

Citations

Page 1

	Year	Citations
Analysis of protein-coding genetic variation in 60,706 humans Monkol Lek, Konrad J. Karczewski, Eric Vallabh Minikel, Nature Phenotypic VariationProtein-coding Genetic VariationGeneticsHuman PolymorphismGenomics	2016	10.1K
The mutational constraint spectrum quantified from variation in 141,456 humans Konrad J. Karczewski, Laurent C. Francioli, Grace Tiao, Nature	2020	9.6K
Dapagliflozin in Patients with Chronic Kidney Disease Hiddo J.L. Heerspink, Bergur V. Stefánsson, Ricardo Correa‐Rotter, New England Journal of Medicine	2020	4.8K
Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis David Adams, Alejandra González‐Duarte, William O’Riordan, New England Journal of Medicine	2018	2.8K
A multisociety Delphi consensus statement on new fatty liver disease nomenclature Mary E. Rinella, Jeffrey V. Lazarus, Vlad Ratziu, Hepatology Evidence-based MedicinePathologyFatty Liver DiseaseObesityMetabolic Syndrome	2023	2.5K
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)<sup>1</sup> Daniel J. Klionsky, Amal Kamal Abdel‐Aziz, Sara Abdelfatah, Autophagy	2021	2.5K
2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus Martin Aringer, Karen H. Costenbader, David Daikh, Arthritis & Rheumatology	2019	2.3K
Nivolumab plus Cabozantinib versus Sunitinib for Advanced Renal-Cell Carcinoma Toni K. Choueiri, Thomas Powles, Mauricio Burotto, New England Journal of Medicine	2021	1.6K
A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus Richard Furie, Michelle Petri, Omid Zamani, Arthritis & Rheumatism	2011	1.6K
Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: The lupus nephritis assessment with rituximab study Brad H. Rovin, Richard Furie, Kevin Latinis, Arthritis & Rheumatism	2012	1.4K

Page 1